Business

Announcement on Voluntary Disclosure of Adding API Supplier for Albuvirtide for Injection and Subsidiary Sichuan Frontier Biopharmaceutical Co., Ltd. Passing Drug GMP Compliance Inspection

Announcement on Voluntary Disclosure of Adding API Supplier for Albuvirtide for Injection and Subsidiary Sichuan Frontier Biopharmaceutical Co., Ltd. Passing Drug GMP Compliance Inspection

articleFrontier Biotechnologies Inc. Class ANovember 6, 20244/news/announcement-on-voluntary-disclosure-of-adding-api-supplier-for-albuvirtide-for-injection-and-subsidiary-sichuan-frontier-biopharmaceutical-co-ltd-passing-drug-gmp-compliance-inspection
Announcement on Voluntary Disclosure of Adding API Supplier for Albuvirtide for Injection and Subsidiary Sichuan Frontier Biopharmaceutical Co., Ltd. Passing Drug GMP Compliance Inspection

About this update from Frontier Biotechnologies Inc. Class A

Announcement on Voluntary Disclosure of Adding API Supplier for Albuvirtide for Injection and Subsidiary Sichuan Frontier Biopharmaceutical Co., Ltd. Passing Drug GMP Compliance InspectionThe abstract is for reference only. Please refer to the full text of the announcement on the very day.Link of Full Text for Reference: View Attachment

View stock analysis, news, and events for Frontier Biotechnologies Inc. Class A